Abstract
Purpose
The data on the prognostic significance of red cell distribution width (RDW) in gallbladder cancers is sparse, especially in the potentially resectable cohort of patients. The aim was to assess the prognostic significance of RDW in gallbladder cancer patients undergoing surgery.
Methods
Retrospective analysis of prospectively maintained database of gallbladder cancer patients undergoing surgery at a tertiary cancer institute from 2010 till 2018. Baseline values were collected. Patients were grouped as per the median RDW value and compared. Survival analysis was done using the Kaplan Meier method.
Results
A total of 605 patients were included. The median follow up period was 23 months (range: 6–120 months). The median value of RDW was 14. Comparison between RDW > 14 and RDW < 14 groups showed no difference in outcomes. RDW did not predict overall survival or recurrences. However, in combined stages II and III, a statistically significant improvement in OS and DFS (p < 0.001) was noted in the RDW < 14 group.
Conclusion
RDW did not predict recurrence or survival in potentially resectable gallbladder cancer patients. However, in the subset of stages II and III in combination, lower RDW value was associated with better outcomes. More prospective studies are needed to conclusively establish the prognostic value of RDW.
Similar content being viewed by others
References
Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211–7.
Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, et al. Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol. 2017;117(3):372–9.
Ellingsen TS, Lappegård J, Skjelbakken T, Brækkan SK, Hansen JB. Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study. Hematologica. 2015;100(10):e387–9.
Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, et al. Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients. Contemp Oncol (Pozn). 2016;20:153–7.
Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. Plos One. 2013;8.
Yao MY, Liu Y, Jin HL, Liu XJ, Lv KZ, Wei HY, et al. Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer. Onco Targets Ther. 2014;7:1743–52.
Huang DP, Ma RM, Xiang YQ. Utility of red cell distribution width as a prognostic factor in young breast cancer patients. Medicine. 2016; 95(17):e3430.
Hirahara N, Matsubara T, Kawahara D, Mizota Y, Ishibashi S, Tajima Y. Prognostic value of haematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Clin Oncol. 2016;21:909–19.
Sun P, Zhang F, Chen C, Bi X, Yang H, An X, et al. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern china. Oncotarget. 2016;7:42650–60.
Zhao T, Cui LJ, Li AJ. The significance of RDW in patients with hepatocellular carcinoma after radical resection. Cancer Biomark. 2016;16:507–12.
Smirne C, Grossi G, Pinato DJ, Burlone ME, Mauri FA, Januszewski A, et al. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Dig Liver Dis. 2015;47:488–94.
Wang FM, Xu G, Zhang Y, Ma LL. Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers. 2014;2014:860419.
Cheng YC, Huang CN, Wu WJ, Li CC, Ke HL, Li WM, et al. The prognostic significance of inflammation-associated blood cell markers in patients with upper tract urothelial carcinoma. Ann Surg Oncol. 2016;23:343–51.
Li Y, Xing C, Wei M, Wu H, Hu X, Li S, et al. Combining red blood cell distribution width (RDW-CV) and CEA predict poor prognosis for survival outcomes in colorectal cancer. J Cancer. 2019;10(5):1162–70.
Abakay O, Tanrikulu AC, Palanci Y, Abakay A. The value of inflammatory parameters in the prognosis of malignant mesothelioma. J Int Med Res. 2014;42:554–65.
Iriyama N, Hatta Y, Kobayashi S, Uchino Y, Miura K, Kurita D, et al. Higher red blood cell distribution width is an adverse prognostic factor in chronic-phase chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Anticancer Res. 2015;35:5473–8.
Liu F, Hu HJ, Ma WJ, Yang Q, Wang JK, Li FY. Prognostic significance of neutrophil–lymphocyte ratio and carbohydrate antigen 19–9 in patients with gallbladder carcinoma. Medicine (Baltimore). 2019;98(8):e14550
Pang Q, Zhang LQ, Wang RT, Bi JB, Zhang JY, Qu K, et al. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol. 2015;21(21):6675–83.
Xie Y, Zhang L, Zhan L. Can we assess the advancements of gallbladder cancer using red blood cell distribution width? Medicine (Baltimore). 2019;98(51):e18364.
Gupta A, Gupta S, Gupta A, Gupta A, Goyal B, Agrawal S, et al. Red cell distribution width: a surrogate biomarker to predict tumor burden in carcinoma gallbladder. Niger J Surg. 2019;25(2):198–202.
Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. Ann Surg Oncol. 2018;25:845–7.
Engineer R, Patkar S, Lewis SC, Sharma AD, Shetty N, Ostwal V, et al. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol. BMJ Open. 2019;9:e028147
Beyazit Y, Kekilli M, Ibis M, Kurt M, Sayilir A, Onal IK, et al. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis Hepatogastroenterology. 2012;59(117):1469–73.
John A, Kaman L, Behera A, Dahya D, Das R. Role of red cell distribution width and other blood cell indices in differentiating between benign and malignant diseases of gallbladder. HPB. 2018;20:S707–8.
Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–7.
Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277(1–2):103–8.
Hu L, Li M, Ding Y, Pu L, Liu J, Xie J, et al. Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(9):16027–35.
Tang H, Lu W, Li B, Li C, Xu Y, Dong J. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(22):36857–68.
Acknowledgements
We would like to thank Dr. Mahesh for the statistical analysis.
Author information
Authors and Affiliations
Contributions
All the authors have equally contributed to the manuscript in relation to conceptualization, drafting writing and editing.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kattepur, A.K., Patkar, S., Ramaswamy, A. et al. Red Cell Distribution Width and Gallbladder Cancer: Is It Really Useful?. J Gastrointest Canc 53, 995–1005 (2022). https://doi.org/10.1007/s12029-021-00742-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-021-00742-7